Crispr Therapeutics AG stock forecast
Want to see CRSP full AI Analyst Report?
Crispr Therapeutics AG (CRSP) Stock Forecast & Price Target
CRSP Analyst Ratings
CRSP Stock 12 Month Forecast
Average Price Target
$71.83▲(70.06% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | $80 | buy | 89.39%Upside | Reiterated | 11/10/26 | ||
| Gil Blum | Needham | $82 | buy | 94.13%Upside | Reiterated | 11/10/26 | ||
| Edward Tenthoff | Piper Sandler | $110 | buy | 160.42%Upside | Reiterated | 11/09/26 | ||
| Brian Cheng | J.P. Morgan | $67 | buy | 58.62%Upside | Reiterated | 11/09/26 | ||
| Joon Lee | UBS | $52 | hold | 23.11%Upside | Reiterated | 11/09/26 | ||
| Yigal Nochomovitz | Citi | $90 | buy | 113.07%Upside | Reiterated | 11/08/26 | ||
| Yanan Zhu | Wells Fargo | $75→$70 | hold | 65.72%Upside | Assigned | 11/04/26 | ||
| Alec Stranahan | Bank of America Securities | $79→$80 | buy | 89.39%Upside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | $50 | hold | 18.37%Upside | Reiterated | 11/03/26 | ||
| Tyler Van Buren | TD Cowen | $45 | hold | 6.53%Upside | Reiterated | 10/21/26 | ||
| Jonathan Miller | Evercore ISI | $76 | buy | 79.92%Upside | Reiterated | 08/31/26 | ||
| Maxwell Skor | Morgan Stanley | $60 | hold | 42.05%Upside | Reiterated | 08/28/26 | ||
| Sami Corwin | William Blair | ― | buy | ― | Reiterated | 08/28/26 | ||
| Salveen Richter | Goldman Sachs | $48→$55 | hold | 30.21%Upside | Assigned | 08/10/26 | ||
| Silvan Turkcan | Citizens JMP | $80 | buy | 89.39%Upside | Reiterated | 07/22/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Mitchell KapoorH.C. Wainwright | BuyReiterated$80 | 11/10/26 | 89.39%Upside | ||
| Gil BlumNeedham | BuyReiterated$82 | 11/10/26 | 94.13%Upside | ||
| Edward TenthoffPiper Sandler | BuyReiterated$110 | 11/09/26 | 160.42%Upside | ||
| Brian ChengJ.P. Morgan | BuyReiterated$67 | 11/09/26 | 58.62%Upside | ||
| Joon LeeUBS | HoldReiterated$52 | 11/09/26 | 23.11%Upside | ||
| Yigal NochomovitzCiti | BuyReiterated$90 | 11/08/26 | 113.07%Upside | ||
| Yanan ZhuWells Fargo | HoldAssigned$75→$70 | 11/04/26 | 65.72%Upside | ||
| Alec StranahanBank of America Securities | BuyReiterated$79→$80 | 11/04/26 | 89.39%Upside | ||
| Luca IssiRBC Capital | HoldReiterated$50 | 11/03/26 | 18.37%Upside | ||
| Tyler Van BurenTD Cowen | HoldReiterated$45 | 10/21/26 | 6.53%Upside | ||
| Jonathan MillerEvercore ISI | BuyReiterated$76 | 08/31/26 | 79.92%Upside | ||
| Maxwell SkorMorgan Stanley | HoldReiterated$60 | 08/28/26 | 42.05%Upside | ||
| Sami CorwinWilliam Blair | BuyReiterated | 08/28/26 | ― | ||
| Salveen RichterGoldman Sachs | HoldAssigned$48→$55 | 08/10/26 | 30.21%Upside | ||
| Silvan TurkcanCitizens JMP | BuyReiterated$80 | 07/22/26 | 89.39%Upside |
Best Analysts Covering Crispr Therapeutics AG
Copying Geulah Livshits's trades and holding each position for 3 Months would result in 52.78% of your transactions generating a profit, with an average return of +9.70% per trade.
Copying Alec Stranahan's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +6.44% per trade.
Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 36.00% of your transactions generating a profit, with an average return of -5.17% per trade.
CRSP Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 7 | 10 |
| Buy | 7 | 8 | 7 | 7 | 4 |
| Hold | 6 | 8 | 7 | 9 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 25 | 22 | 23 | 21 |
In the current month, CRSP has received 14 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CRSP average Analyst price target in the past 3 months is 71.83.
CRSP Financial Forecast
CRSP Earnings Forecast
Next quarter’s earnings estimate for CRSP is -$1.17 with a range of -$2.14 to -$0.75. The previous quarter’s EPS was -$1.15. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CRSP Sales Forecast
Next quarter’s sales forecast for CRSP is $11.34M with a range of $0 to $56.58M. The previous quarter’s sales results were $12.67M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

